Noam Fishman serves as Associate Director, Market Research and Competitive Intelligence at Ferring Pharmaceuticals, where he supports business stakeholders through market research, competitive intelligence, forecasting, and analytics. He is part of the Insights and Analytics team within Commercial Operations and is based in Parsippany, New Jersey.
[office.com]In his role, Noam supports stakeholders across Commercial, Brand, Market Access, Business Development, New Product Planning, and Launch Excellence. His current remit includes competitive intelligence efforts for Ferring's bladder cancer product, Adstiladrin, as well as SI-6603 (Condoliase), an investigational orthopedic therapy. He translates complex market dynamics into actionable business insights, helping leaders understand evolving market conditions, anticipate market shifts, evaluate competitive threats, identify opportunities to improve commercial performance, assess risks, and make evidence-based decisions. His work spans competitive intelligence, market research, forecasting, and commercial analytics, with a focus on monitoring competitive landscapes, evaluating pipeline and in-market threats, and delivering strategic insights that inform commercial planning, forecasting, and executive decision-making.
